company background image
4572 logo

Carna Biosciences TSE:4572 Stock Report

Last Price

JP¥468.00

Market Cap

JP¥7.9b

7D

-0.6%

1Y

0.4%

Updated

27 Mar, 2024

Data

Company Financials

4572 Stock Overview

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

4572 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Carna Biosciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Carna Biosciences
Historical stock prices
Current Share PriceJP¥468.00
52 Week HighJP¥1,060.00
52 Week LowJP¥414.00
Beta1.24
1 Month Change4.23%
3 Month Change-12.36%
1 Year Change0.43%
3 Year Change-65.44%
5 Year Change-56.63%
Change since IPO-55.00%

Recent News & Updates

Recent updates

Health Check: How Prudently Does Carna Biosciences (TYO:4572) Use Debt?

Apr 11
Health Check: How Prudently Does Carna Biosciences (TYO:4572) Use Debt?

How Much Did Carna Biosciences'(TYO:4572) Shareholders Earn From Share Price Movements Over The Last Five Years?

Feb 17
How Much Did Carna Biosciences'(TYO:4572) Shareholders Earn From Share Price Movements Over The Last Five Years?

Health Check: How Prudently Does Carna Biosciences (TYO:4572) Use Debt?

Dec 26
Health Check: How Prudently Does Carna Biosciences (TYO:4572) Use Debt?

Shareholder Returns

4572JP Life SciencesJP Market
7D-0.6%1.0%1.0%
1Y0.4%-29.6%38.6%

Return vs Industry: 4572 exceeded the JP Life Sciences industry which returned -29.6% over the past year.

Return vs Market: 4572 underperformed the JP Market which returned 38.6% over the past year.

Price Volatility

Is 4572's price volatile compared to industry and market?
4572 volatility
4572 Average Weekly Movement5.2%
Life Sciences Industry Average Movement6.0%
Market Average Movement3.9%
10% most volatile stocks in JP Market8.3%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4572 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4572's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200365Kohichiro Yoshinohttps://www.carnabio.com

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection and interaction, live-cell kinase assay, and tyrosine kinase cell-based assay services.

Carna Biosciences, Inc. Fundamentals Summary

How do Carna Biosciences's earnings and revenue compare to its market cap?
4572 fundamental statistics
Market capJP¥7.94b
Earnings (TTM)-JP¥1.15b
Revenue (TTM)JP¥1.63b

4.9x

P/S Ratio

-7.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4572 income statement (TTM)
RevenueJP¥1.63b
Cost of RevenueJP¥175.00m
Gross ProfitJP¥1.45b
Other ExpensesJP¥2.60b
Earnings-JP¥1.15b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-67.19
Gross Margin89.23%
Net Profit Margin-70.89%
Debt/Equity Ratio3.8%

How did 4572 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.